Fenoy, Albert J.
Schulz, Paul E.
Selvaraj, Sudhakar
Burrows, Christina L.
Zunta-Soares, Giovanna
Durkin, Kathryn
Zanotti-Fregonara, Paolo
Quevedo, Joao
Soares, Jair C.
Article History
Received: 1 March 2018
Accepted: 15 April 2018
First Online: 4 June 2018
Conflict of interest
: Dr. Soares receives grant/research support from Bristol-Meyers Squibb, Forest Laboratories, Merck and Elan Pharmaceuticals, and is a consultant for Pfizer, Abbot, and Astellas Pharma, Inc. Dr. Zanotti-Fregonara has received fees as a speaker for Eli Lilly. The remaining authors declare no conflict of interest.